Phytosomes: Complexation, Utilisation and Commerical Status

Journal of Biologically Active Products from Nature

Volumn 2, Issue 2, 2012, Pages 65-77

  Agarwal, Apoorva ^a   Chakraborty, Prithviraj ^a   Chakraborty, Debarupa D ^a   Saharan, Vikas Anand ^a  

^a Sardar Bhagwan Singh Post Gratudate Institute of Biomedical Sciences & Research   (India)

Author keywords

bioavailability; lipolysis; phospholipids; Phytosomes; polyphenols

Indexed keywords

EID: 85008395607     PISSN: 22311866     EISSN: 22311874     Source Type: Journal    
DOI: 10.1080/22311866.2012.10719111     Document Type: Article

References (96)

1. Hauss, D.J., 2007. Oral lipid-based formulations. Advanced Drug Delivery Reviews, 59: 667–676.
2. Gursoy, R.N., and Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapeutics, 58 (3): 173–182.
3. Lipinski, C.A., 2000. Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44: 235–249.
4. Vonderscher, J., and Meinzer, A., 1994. Rationale for the development of Sandimmune Neoral. Transplant Proceedings, 26: 2925–2927.
5. Wandel, C., Kim, R.B., and Stein, M., 2003. “Inactive” excipients such as Cremophor can affect in vivo drug disposition. Clinical Pharmacology and Therapeutics, 73 (5): 394–396.
6. Cornaire, G., Woodley, J., Hermann, P., Cloare, A., Arellano, C., and Houin, G., 2004. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. International Journal of Pharmaceutics, 278: 119–131.
7. Rege, B., Kao, J., and Polli, J., 1992. Effects of nonionic surfactants on membrane transporters inCaco-2 cell monolayers. Journal of Pharmaceutical Sciences, 16: 237–246.
8. Charman, W.N., 1992. “ Lipid vehicle and formulation effects on intestinal lymphatic drug transport ”. In Lymphatic Transport of Drugs, Edited by: Charman, W.N., and Stella, V.J., 113–179. Boca Raton: CRC Press.
9. Hauss, D.J., Fogal, S.E., and Ficorilli, J.V., 1998. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. Journal of Pharmaceutical Sciences, 87: 164–169.
10. Bhattacharya, S., and Ghosh, A., 2009. Phytosomes: the Emerging Technology for Enhancement of Bioavailability of Botanicals and Nutraceuticals. International Journal of Health Research, 2 (3): 225–232.
11. Bombardelli, E., Curri, S.B., Della Loggia, R., 1989. Complexes between phospholipids and vegetal derivatives of biological interest. Fitoterapia, 60: 1–9.
12. Kidd, P.M., 2009. Bioavailability and Activity of Phytosome Complexes from Botanical Polyphenols: The Silymarin, Curcumin, Green Tea, and Grape Seed Extracts. Alternative Medicine Review, 14 (3): 226–246.
13. Manach, C., Scalbert, A., Morand, C., 2004. Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition, 79: 727–747.
14. Jose, M.M., and Bombardelli, E., 1987. U.S. Patent No-EPO209037. Pharmaceutical compositions containing flavanolignans and phospholipida active principles.
15. Semalty, A., Semalty, M., Singh, D., and Rawat, MSM., 2009. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. Journal of Inclusion Phenomena and Macrocyclic Chemistry, DOI 10.1007/s009–8
16. Awasthi, R., Kulkarni, G.T., and Pawar, V.K., 2011. Phytosomes: an approach to increase the bio-availability of plant extracts. International Journal of Pharmacy and Pharmaceutical Sciences, 3 (2): 1–3.
17. Kumar, V.S., and Kesari, A., 2011. Herbosome: A novel carrier for herbal drug delivery. International Journal of Current Pharmaceutical Research, 3 (3): 36–41.
18. Bombardelli, E., 1994. Phytosome in functional cosmetics. Fitoterapia, LXV (5): 387–401.
19. Saonere Suryawanshi, J.A., 2011. Phytosome: An emerging trend in herbal drug treatment. Journal of Medical Genetics and Genomics, 3 (6): 109–114.
20. Sharma, S., and Sikarwar, M., 2005. Phytosome: A Review. Planta. Indica, 1 (2): 1–3.
21. Stuchlik, M., and Zak, S., 2001. Lipid based vehicle for oral drug delivery. Biomedical papers, 145 (2): 17–26.
22. Magistretti, M.J., and Bombardelli, E., 1987. U.S. Patent No-EPO209037. Phamaceutical compositions containing flavanolignans and phospholipida active principles.
23. Raju, T.P., Reddy, M.S., and Reddy, V.P. 2011. Phytosomes: A novel phyto-phospholipid carriers for herbal drug delivery. International Research Journal of Pharmacy, 2 (6): 28–33.
24. Mascarella, S., 1993. Therapeutic & antilipoperoxidant effects of silybin phosphatidyl choline complex in chronic liver disease. Current Therapeutic Research, 53: 98–102.
25. Fry, D.W., 1978. White JC. Goldman ID. Rapid secretion of low molecular weight solutes from liposomes without dilution. Analytical Biochemistry, 90: 809–815.
26. Franco, P.G., 1998. US Patent No-EPO 275005. Bombardelli E. Complex coppouns of bioflavanoids with phospholipids, their preparation and uses and pharmaceutical and cosmetic compositions containing them.
27. Bombardelli, E., and Giuseppe, M., 1991. U.S.Patent No. EPO 441279 B1. Bilobalide phospholipide complex, their applications and formulation containing them.
28. Semalty, A., Semalty, M., and Rawat, M.S.M., 2007. The phytophospholipid complexes phytosomes: A potential therapeutic approach for herbal hepatoprotective drug delivery. Pharmacognosy Reviews, 1: 369–374.
29. Vasanti, S. (2008). Phytosomes: A short review. http://www.biology-online.org/articles/phytosomes-short-review.Html
30. Liposomes: A Practical Approach, Preparation of liposomes and size determination. (1990). New RRC (Ed.), Oxford University Press, 36–39
31. Bombardelli, E., 1991. Phytosome: a new cosmetic delivery system. Boll Chim Farm., 130: 431–438.
32. Bombardelli, E., and Spelta, M., 1991. Phospholipid-polyphenol complexes: A new concept in skin care ingredients. Cosmetics and Toiletries, 106: 69–76.
33. Dubey, D., Shrivastava, S., Kapoor, S. (2007). Phytosome: a novel dosage structure. http://www.pharmainfo.net/reviews/
34. Kingdom, A.D., 2001. Pharmacognosy in 21st century. Journal of Pharmacognosy and Pharmacology, 53: 135–148.
35. Kidd, P., and Head, K., 2005. A review of bioavailability and clinical efficacy of milk thistle phytosome: a silybin phosphatidylcholine complex. Alternative Medicine Reviews, 10 (3): 193–203.
36. Bombardelli, E., Spelta, M., Loggia Della, R., Sosa, S., and Tubaro, A., 1991. Aging skin: Protective effect of silymarin-Phytosome. Fitoterapia, 62 (2): 115–22.
37. Gupta, A., Ashawal, M.S., and Saraf, S., 2007. Phytosomes: A novel approach towards functional cosmetics. Journal of Plant Science,: 644–649.
38. Marena, C., and Lampertico, M., 1991. Preliminary clinical development of silipide: A new complex of silybin in toxic liver disorders. Planta Medica., 57: A124–A125.
39. Kidd, P.M., 2002. “ Phosphatidylcholine ”. In Alternative Medicine Review Monographs Volume One, Edited by: Czap, K, Miller, AL, Head, KA. 310–315. Dover, ID: Thorne Research, Inc.
40. Dayan, N., and Touitou, E., 2002. Carrier for skin delivery of trihexyphenidyl HCl: ethosomes vs liposomes. Biomaterials, 21: 1879–1885.
41. Citernesi, U., and Sciacchitano, M., 1995. Phospholipids/active ingredient complexes. Cosmetics & Toiletries, 110: 57–68.
42. Patel, J., Patel, R., Khambholjab, K., and Patel, N., 2009. An overview of phytosomes as an advanced herbal drug delivery system. Asian Journal of Pharmaceutical Sciences, 4 (6): 363–371.
43. Porter, C.J.H., Trevaskis, N.L., and Charman, W.N., 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature Reviews Drug Discovery, 6: 231–248.
44. Borovicka, J., 1997. Regulation of gastric and pancreatic lipase secretion by CCK and cholinergic mechanisms in humans. American Journal of Physiology, 273: G374–G380.
45. Moreau, H., 1989. Immunocytolocalization of human gastric lipase in chief cells of the fundic mucosa. Histochemistry, 91: 419–423.
46. Thomson, A.B.R., Keelan, M., Garg, M.L., and Clandinin, M.T., 1989. Intestinal aspects of lipid absorption: in review. Canadian Journal of Physiology and Pharmacology, 67: 179–191.
47. Hamosh, M., 1981. Fat digestion in the newborn-Characterization of lipase in gastric aspirates of premature and term infants. Journal of Clinical Investigation, 67: 838–846.
48. Abrams, C.K., 1988. Gastric lipase: localization in the human stomach. Gastroenterology, 95: 1460–1464.
49. Van den Bosch, H., Postema, N.M., De Haas, G.H., and Van Deenen, L.L., 1965. On the positional specificity of phospholipase A from pancreas. Biochimica et Biophysica Acta, 98: 657–659.
50. Borgstrom, B., Dahlqvist, A., Lundh, G., and Sjovall, J., 1957. Studies of intestinal digestion and absorption in the human. Journal of Clinical Investigation, 36: 1521–1536.
51. Duane, W.C., Ginsberg, R.L., and Bennion, L.J., 1976. Effects of fasting on bile acid metabolism and biliary lipid composition in man. Journal of Lipid Research, 17: 211–219.
52. Thomson, A.B., Schoeller, C., Keelan, M., Smith, L., and Clandinin, M., 1993. Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Canadian Journal of Physiology and Pharmacology, 71: 531–555.
53. Jain, N.K., 2005. Liposomes as drug carriers, controlled and novel drug delivery., 1st, 321–326. CBS publisher.
54. Maghraby, G.M.M., Williams, A.C., and Barry, B.W., 2000. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. International Journal of Pharmaceutics, 196: 63–74.
55. Pandey, S., and Patel, K., 2010. Phytosomes: Technical revolution in phytomedicine. International Journal of PharmaTech Research, 2: 627–631.
56. Berge BAI, V., Swartzendruber, V.A.B., and Geest, J., 1997. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. Journal of Microscopy, 187: 125–133.
57. Chauhan, N.S., Gowtham, R., and Gopalkrishna, B., 2009. Phytosomes: A potential Phyto-phospholipid carriers for herbal drug delivery. Journal of Pharmacy Research, 2: 1267–70.
58. Facino, R.M., Carini, M., and Aldini, G., 1994. Free radicals sea action and anti-enzyme activities of procyanidines vitis vinifera-a mechanism for their capillary protection. Arzneimittelforschung, 44: 592–601.
59. Porter, C.J.H., and Charman, W.N., 2001. In vitro assessment of oral lipid based formulations. Advanced Drug Delivery Reviews, 50: S127–S147.
60. Christensen, J.O., Schultz, K., Mollgaard, B., Kristensen, H.G., and Mullertz, A., 2004. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium-and long-chain triacylglycerols. European Journal of Pharmaceutical Sciences, 23: 287–296.
61. Kidd, P.M., 2002. “ Glutathione ”. In Alternative Medicine Review Monographs, Volume One, Edited by: Czap, K., Miller, A.L., Head, K.A., 184–192. Dover, ID: Thorne Research, Inc.
62. Malandrino, S., and Pifferi, G., 1990. IdB-1016. Drugs Future, 15: 226–227.
63. Barzaghi, N., Crema, F., and Gatti, G., 1990. Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. European Journal of Drug Metabolism and Pharmacokinetics, 15: 333–338.
64. http://www.indena.com/pdf/ephytosome.pdf Accessed-Oct 11, 2011
65. Bares, J.M., Berger, J., Nelson, J.E., 2008. Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C. Journal of clinical Gastroenterology, 42: 937–944.
66. Ramasamy, K., and Agarwal, R., 2008. Multitargeted therapy of cancer by silymarin. Cancer Letters, 269: 352–362.
67. Manna, S.K., Mudkopadhyay, A., Van, N.T., and Aggarwal, B.B., 1999. Silymarin suppresses TNF-induced activation of NF-kappaB, c-Jun N-terminal kinase, and apoptosis. Journal of Immunology, 163: 6800–6809.
68. Schandalik, R., Gatti, G., and Perucca, E., 1992. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Arzneimittelforschung, 42: 964–968.
69. Goel, A., Kunnumakkara, A.B., and Aggarwal, B.B., 2008. Curcumin as “Curecumin”: from kitchen to clinic. Biochemical Pharmacology, 75: 787–809.
70. Soni, K.B., and Kuttan, R., 1992. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian Journal of Physiology and Pharmacology, 36: 273–275.
71. Garcea, G., Berry, D.P., and Jones, D.J., 2005. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiology, Biomarkers and Prevention, 14: 120–125.
72. Villegas, I., Sanchez-Fidalgo, S., and Alarcon de la Lastra, C., 2008. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Molecular Nutrition and Food Research, 52: 1040–1061.
73. Strimpakos, A.S., and Sharma, R.A. 2008. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxidants and Redox Signaling, 10: 511–545.
74. Begum, A.N., Jones, M.R., and Lim, G.P., 2008. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. Journal of Pharmacology and Experimental Therapeutics, 326: 196–208.
75. Marczylo, T.H., Verschoyle, R.D., and Cooke, D.N., 2007. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemotherapy and Pharmacology, 60: 171–177.
76. Coyle, C.H., Philips, B.J., and Morrisroe, S.N., 2008. Antioxidant effects of green tea and its polyphenols on bladder cells. Life Sciences, 83: 12–18.
77. Krahwinkel, T., and Willershausen, B., 2000. The effect of sugar-free green tea chew candies on the degree of inflammation of the gingiva. European Journal of Medical Research, 5: 463–467.
78. Di Pierro, F., Menghi, A.B., and Barreca, A., 2009. Greenselect® phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Alternative Medicine Reviews, 14: 154–160.
79. Zhao, B., Guo, Q., and Xin, W., 2001. Free radical scavenging by green tea polyphenols. Methods in Enzymology, 335: 217–231.
80. Khan, N., Afaq, F., and Saleem, M., 2006. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research, 66: 2500–2505.
81. Mandel, S.A., Avramovich-Tirosh, Y., and Reznichenko, L., 2005. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signalling pathway. Neurosignals, 14: 46–60.
82. Simonetti, P., Ciappellano, S., and Gardana, C., 2002. Procyanidins from Vitis vinifera seeds: in vivo effects on oxidative stress. Journal of Agricultural and Food Chemistry, 50: 6217–6221.
83. Maffei Facino, R., Carini, M., and Aldini, G., 1994. Free radicals scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 44: 592–601.
84. Natella, F., Belelli, F., and Gentili, V., 2002. Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans. Journal of Agricultural and Food Chemistry, 50: 7720–7725.
85. Morazzoni, P., Cristoni, A., Bombardelli, E., Saponara, R., and Bosisio, E., (0000). Inhibition of phosphodiesterases by Ginkgo Biloba Dimeric Flavonoids and modulation of skin microcirculation and adipocytes lipolysis-Proceedings of the 20th IFSCC Congress
86. Indena. Gingko biloba Dimeric flavanoids Phytosomes®, Available at: http://www.indena.com/pdf/GBDFPhytosome.pdf. Accessed-Oct 11, 2011
87. Indena. Gingko biloba Terpenes Phytosomes®, Available at: http://www.indena.it/pdf/gbterpenesphytosome.pdf. Accessed-Oct 11, 2011
88. For the United States of America: http://www.rxlist.com, http://www.fda.gov/cder, http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm; For the United Kingdom: http://emc.medicines.org.uk/; For Japan: http://www.e-search.ne.jp/~jpr/jprdb/eindex.htmlAccessed Oct 11, 2011
89. Phytosomes: A technical revolution in phytomedicine. Available at: http://www.indena.com. Accessed-Oct 11, 2011
90. Indena. Formulating Phytosomes®, Available at: http://www.phytosomes.info/public/formulating_phytosome.asp. Accessed-Oct 11, 2011
91. Sindhumol, P.G., Thomas, M., and Mohanachandran, P.S., 2010. Phytosomes: A novel dosage form for enhancement of bioavailability of botanicals and neutraceuticals. International Journal of Pharmacy and Pharmaceutical Sciences, 2 (4): 10–14.
92. Murray. Phytosomes-Increase the absorption of herbal extract, Available at: http://www.doctormurray.com/articles/silybin.htm Accessed-Oct 11, 2011
93. Vitamedics, Phytosome Products, Available at http://www.vitaemedics.com. Accessed-Oct 11, 2011
94. Mukherjee, P.K., Maiti, K., and Kumar, V., 2007. Value added drug delivery systems with botanicals: Approach for Dosage development from natural resources. Pharma Reviews, 6: 57–60.
95. Joshi, A., Chaturvedi, S., and Kumar, V., 2007–08. Phytosomes-A revolution in herbal drugs, Pharma Review, Kongposh Publications.
96. Indena. Phytosomes®: More bioavailable, Available at: http://www.indena.it/pdf/phytosome.pdf. Accessed-Oct 11, 2011